Cabot Wealth Management’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$99.3K Hold
88,623
– – 0.01% 152
2026
Q2
$109K Hold
88,623
– – 0.01% 142
2026
Q1
$62.3K Hold
88,623
– – 0.01% 139
2025
Q4
$137K Buy
+88,623
New +$142K 0.02% 138

Other funds holding MXCT

Cabot Wealth Management's MXCT Position: Q3 2026 in Review

Cabot Wealth Management held its MaxCyte (MXCT) position steady in Q3 2026 at 88,623 shares worth $99.3K. The position accounts for 0.01% of the portfolio, ranked #152.

Cabot Wealth Management first reported a position in MXCT in Q4 2025 and has held it in 4 quarters since. The position peaked at $137K in Q4 2025. 31 funds tracked by Wall St. Rank hold MXCT as of Q3 2026.

  • Cabot Wealth Management held 88,623 shares of MaxCyte worth $99.3K as of Q3 2026.
  • Cabot Wealth Management left its MaxCyte share count unchanged in Q3 2026.
  • MaxCyte made up 0.01% of Cabot Wealth Management's portfolio in Q3 2026, its #152 holding.
  • Cabot Wealth Management first reported a position in MaxCyte in Q4 2025 and has held it in 4 quarters since.
  • Cabot Wealth Management's MaxCyte position peaked at $137K in Q4 2025.
  • 31 funds tracked by Wall St. Rank held MaxCyte as of Q3 2026.

Based on Cabot Wealth Management's 13F filing for Q3 2026, filed 5 Nov 2026.